Literature DB >> 17454311

Effect of astragaloside on cardiomyocyte apoptosis in murine coxsackievirus B3 myocarditis.

Z-C Zhang1, S-J Li, Y-Z Yang, R-Z Chen, J-B Ge, H-Z Chen.   

Abstract

Astragaloside is the major component of Astragalus membranaceus, one of the Chinese medical herbs, and has several pharmacological actions on cardiovascular system, including positive inotropic, anti-arrhythmia and anti-oxidant activities. We have investigated the effect of astragaloside on cardiomyocyte apoptosis and expression of apoptosis-associated genes in mice with coxsackievirus B(3) (CVB(3))-induced myocarditis, the former of which has been detected by terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end-labeling (TUNEL) assay and the latter determined by using a focused microarray. Results showed that cardiomyocyte apoptosis and expression of various apoptosis associated genes are inhibited after treatment with astragaloside. The anti-apoptotic activity of astragaloside may contribute to the improvement of clinical outcomes in treating myocarditis with pharmaceutics of Astragalus membranaceus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17454311     DOI: 10.1080/10286020412331286506

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  9 in total

Review 1.  Apoptosis in animal models of virus-induced disease.

Authors:  Penny Clarke; Kenneth L Tyler
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

2.  Astragalus extract inhibits destruction of gastric cancer cells to mesothelial cells by anti-apoptosis.

Authors:  Di Na; Fu-Nan Liu; Zhi-Feng Miao; Zong-Min Du; Hui-Mian Xu
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

3.  Astragaloside IV inhibits oxidative stress-induced mitochondrial permeability transition pore opening by inactivating GSK-3β via nitric oxide in H9c2 cardiac cells.

Authors:  Yonggui He; Jinkun Xi; Huan Zheng; Yidong Zhang; Yuanzhe Jin; Zhelong Xu
Journal:  Oxid Med Cell Longev       Date:  2012-09-25       Impact factor: 6.543

4.  Remission of CVB3-induced myocarditis with Astragaloside IV treatment requires A20 (TNFAIP3) up-regulation.

Authors:  Jun Gui; Ruizhen Chen; Wei Xu; Sidong Xiong
Journal:  J Cell Mol Med       Date:  2015-03-01       Impact factor: 5.310

5.  Astragalus and Baicalein Regulate Inflammation of Mesenchymal Stem Cells (MSCs) by the Mitogen-Activated Protein Kinase (MAPK)/ERK Pathway.

Authors:  Lei Zhu; Ya-Jun Liu; Hong Shen; Pei-Qing Gu; Lu Zhang
Journal:  Med Sci Monit       Date:  2017-07-01

6.  Astragaloside IV reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis.

Authors:  Tianlong Liu; Fan Yang; Jing Liu; Mingjie Zhang; Jianjun Sun; Yunfeng Xiao; Zhibin Xiao; Haiyan Niu; Ruilian Ma; Yi Wang; Xiaolei Liu; Yu Dong
Journal:  Exp Anim       Date:  2019-06-26

7.  Effects of Astragaloside IV on heart failure in rats.

Authors:  Zhuanyou Zhao; Weiting Wang; Fang Wang; Kerui Zhao; Yingmei Han; Weiren Xu; Lida Tang
Journal:  Chin Med       Date:  2009-04-02       Impact factor: 5.455

Review 8.  Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases.

Authors:  Yifei Zhong; Yueyi Deng; Yiping Chen; Peter Y Chuang; John Cijiang He
Journal:  Kidney Int       Date:  2013-07-17       Impact factor: 10.612

9.  Simultaneous determination of nineteen major components in Qi She Pill by ultra-high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Zhongliang Zhang; Qiang Li; Qiufen Li; Simiao Du; Yongquan Zhou; Chunming Lv; Yan Zhao; Yongjun Wang; Ning Zhang
Journal:  Acta Pharm Sin B       Date:  2014-07-15       Impact factor: 11.413

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.